Safety, Pharmacokinetic Study of RVX000222 in Healthy Subjects and Subjects With Low HDL Cholesterol

Clinical Trial ID NCT00768274

PubWeight™ 6.70‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00768274

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Update on strategies to increase HDL quantity and function. Nat Rev Cardiol 2009 1.94
2 Future therapeutic directions in reverse cholesterol transport. Curr Atheroscler Rep 2010 1.46
3 Epigenetic pathway targets for the treatment of disease: accelerating progress in the development of pharmacological tools: IUPHAR Review 11. Br J Pharmacol 2014 0.94
4 Digging deep into "dirty" drugs - modulation of the methylation machinery. Drug Metab Rev 2015 0.83
5 Chemical synthesis of the ATAD2 bromodomain. Proc Natl Acad Sci U S A 2014 0.77
6 Rvx 208. Drugs R D 2011 0.76
Next 100